Free Trial
NASDAQ:RNTX

Rein Therapeutics (RNTX) Stock Price, News & Analysis

Rein Therapeutics logo
$1.51 -0.03 (-1.95%)
As of 07/3/2025 01:00 PM Eastern

About Rein Therapeutics Stock (NASDAQ:RNTX)

Key Stats

Today's Range
$1.44
$1.53
50-Day Range
$1.40
$2.36
52-Week Range
$1.33
$4.40
Volume
8,689 shs
Average Volume
36,172 shs
Market Capitalization
$33.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rein Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RNTX Stock News Headlines

RNTX - Rein Therapeutics Inc Dividends - Morningstar
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
RNTX Rein Therapeutics Inc.
See More Headlines

RNTX Stock Analysis - Frequently Asked Questions

Rein Therapeutics' stock was trading at $2.05 at the beginning of 2025. Since then, RNTX stock has decreased by 26.3% and is now trading at $1.51.

Rein Therapeutics Inc. (NASDAQ:RNTX) posted its earnings results on Thursday, May, 15th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.21) by $0.04.

Shares of RNTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RNTX
Web
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.88 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.44 per share
Price / Cash Flow
3.44
Book Value
$0.43 per share
Price / Book
3.51

Miscellaneous

Free Float
21,024,000
Market Cap
$33.45 million
Optionable
N/A
Beta
1.22
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:RNTX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners